A Clinical Evaluation of Definitive and Clinical Allergic Bronchopulmonary Mycosis
-
- Matsuse Hiroto
- Second Department of Internal Medicine, Nagasaki University School of Medicine
-
- Nakata Hiroko
- Second Department of Internal Medicine, Nagasaki University School of Medicine
-
- Fukahori Susumu
- Second Department of Internal Medicine, Nagasaki University School of Medicine
-
- Tsuchida Tomoko
- Department of Internal Medicine, Goto Central Hospital
-
- Kawano Tetsuya
- Department of Internal Medicine, Senju Hospital
-
- Tomari Shinya
- Department of Internal Medicine, Sasebo City General Hospital
-
- Fukushima Chizu
- Department of Internal Medicine, Nagasaki Kita Hospital
-
- Matsuo Nobuko
- Department of Internal Medicine, Nagasaki Municipal Medical Center
-
- Asai Sadahiro
- Department of Internal Medicine, Sasebo City General Hospital
-
- Kohno Shigeru
- Second Department of Internal Medicine, Nagasaki University School of Medicine
この論文をさがす
抄録
Objective: The present study aims to overcome problems associated with the early diagnosis of allergic bronchopulmonary mycosis (ABPM) using the current criteria.<br> Patients and Methods: Clinical features including radiographic findings from 10 patients with definitive ABPM based on the diagnostic criteria of Rosenberg-Patterson were compared with those from 9 patients with ABPM clinically diagnosed by respiratory allergy specialists.<br> Results: ABPM should be considered in patients with peripheral blood eosinophilia and pulmonary infiltration and/or central bronchiectasis when serum total IgE is elevated. Complication by bronchial asthma suggested ABPM, but was not essential. The expectoration of sputum containing solid components was a critical factor in patients with a history in ABPM. Evaluation of sputum cultures, serum specific IgE antibodies, skin tests and precipitating antibodies were required to establish a diagnosis, but the positive rate of these tests remained low.<br> Conclusions: Even when a definitive diagnosis cannot be established, systemic corticosteroid therapy should be initiated for clinically diagnosed ABPM to prevent irreversible pulmonary dysfunction.<br>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 45 (12), 759-762, 2006
一般社団法人 日本内科学会
- Tweet
キーワード
詳細情報
-
- CRID
- 1390001204870883840
-
- NII論文ID
- 130000076260
-
- COI
- 1:STN:280:DC%2BD28visV2ltw%3D%3D
-
- ISSN
- 13497235
- 09182918
-
- HANDLE
- 10069/22556
-
- PubMed
- 16847364
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可